These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5921889)

  • 21. Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.
    Dans PE; McGehee RF; Wilcox C; Finland M
    Am J Med Sci; 1970 Feb; 259(2):120-32. PubMed ID: 4984031
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic studies on the combination rifampicin-trimethoprim in man. I. Absorption and urinary excretion after administration to healthy volunteers of single doses of the two compounds alone and in combination, and of the combination over a period of 1 week.
    Acocella G; Scotti R
    J Antimicrob Chemother; 1976 Sep; 2(3):271-7. PubMed ID: 977527
    [No Abstract]   [Full Text] [Related]  

  • 24. The place of rifamycin-B-diethylamide in the treatment of cholangitis complicating biliary obstruction.
    Khan GA; Scott AJ
    Br J Pharmacol Chemother; 1967 Nov; 31(3):506-12. PubMed ID: 6083118
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolism of rifampicin in the human body (1st report)].
    Nakagawa H; Sunahara S
    Kekkaku; 1973 May; 48(5):167-76. PubMed ID: 4732656
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rifampicin levels in blood, urine and kidney tissue in patients with renal tuberculosis].
    Mochalova TP; Kanevskaia SS; Danilova NK
    Antibiotiki; 1973 Feb; 18(2):178-80. PubMed ID: 4776397
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 28. Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.
    Acocella G; Mattiussi R; Segre G
    Pharmacol Res Commun; 1978 Mar; 10(3):271-88. PubMed ID: 684036
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and metabolism of rifampin in humans.
    Acocella G
    Rev Infect Dis; 1983; 5 Suppl 3():S428-32. PubMed ID: 6356276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of meals on rifampicin absorption.
    Siegler DI; Bryant M; Burley DM; Citron KM; Standen SM
    Lancet; 1974 Jul; 2(7874):197-8. PubMed ID: 4135611
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum concentrations and biliary excretion of bilirubin during short-term treatment with rifampicin.
    Acocella G; Mattiussi R; Tenconi LT
    Tijdschr Gastroenterol; 1973; 16(3):186-90. PubMed ID: 4742768
    [No Abstract]   [Full Text] [Related]  

  • 32. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic and metabolic studies with labeled rifamycin antibiotics.
    Keberle H; Meyer-Brunot H; Schmid K
    Antimicrob Agents Chemother (Bethesda); 1966; 6():365-70. PubMed ID: 5985259
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental study on rifamicin pharmacodynamics].
    Curci G; Ninni A; Di Mezza F
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):293-314. PubMed ID: 5307453
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical studies with a new rifamycin derivative.
    Cohn HD
    J Clin Pharmacol J New Drugs; 1969; 9(2):118-25. PubMed ID: 4889468
    [No Abstract]   [Full Text] [Related]  

  • 37. Biopharmaceutical study of the hepato-biliary transport of drugs. VII. Improvement of the bioavailability of rifampicin by dosage form design.
    Takada K; Mikami H; Asada S; Tatsuo K; Muranishi S
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):19-24. PubMed ID: 639160
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic study and controlled clinical trials of rifampin.
    Sunahara S; Nakagawa H
    Chest; 1972 Jun; 61(6):526-32. PubMed ID: 5032150
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs.
    Klaassen CD; Plaa GL
    Toxicol Appl Pharmacol; 1969 Sep; 15(2):374-84. PubMed ID: 5808209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.